Hai T, Duffy HA, Lemay JA, Lemay JF. Impact of stimulant medication on behaviour and executive functions in children with attention-deficit/hyperactivity disorder. World J Clin Pediatr 2022; 11(1): 48-60 [PMID: 35096546 DOI: 10.5409/wjcp.v11.i1.48]
Corresponding Author of This Article
Jean François Lemay, MD, FRCPC, Professor, Department of Paediatrics, Alberta Children's Hospital/Cumming School of Medicine, University of Calgary, 28 Oki Drive, NW, Room C4-627, Calgary, AB T3B 6A8, Canada. jf.lemay@ahs.ca
Research Domain of This Article
Pediatrics
Article-Type of This Article
Basic Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Pediatr. Jan 9, 2022; 11(1): 48-60 Published online Jan 9, 2022. doi: 10.5409/wjcp.v11.i1.48
Table 1 Participant demographic information at baseline (T1)
Variable
mean ± SD (n = 37)
Age
10.11 ± 1.27
Cognitive Tasks
WISC-IV-I VC SS
98.11 ± 11.69
WISC-IV-I MR SS
97.70 ± 12.89
BASC-2 Attention Problem T-Score
69.59 ± 6.31
BASC-2 Hyperactivity T-Score
71.73 ± 12.77
WJ-III Reading
90.49 ± 13.19
WJ-III Math
80.95 ± 13.86
WJ-III Written Language
87.03 ± 14.75
Biological Sex
n (%)
Female
16 (43.2)
Male
21 (56.8)
Table 2 Behaviour Assessment System for Children-Second Edition parent symptom reports measured over the three-time points
Variable
BL T-score mean ± SD (n = 37)
BD T-score mean ± SD (n = 30)
BD-BL (P value)
FU T-score mean ± SD (n = 18)
FU-BD (P value)
Externalizing problems
68.95 ± 13.20
54.83 ± 8.42
P < 0.001
63.72 ± 10.26
P = 0.003
Internalizing problems
62.86 ± 15.34
52.53 ± 13.0
P < 0.001
60.89 ± 13.07
P = 0.063
Behaviour symptoms index
72.32 ± 10.20
57.13 ± 7.73
P < 0.001
68.06 ± 9.47
P < 0.001
Adaptive behaviours
33.95 ± 8.92
40.57 ± 9.22
P < 0.001
38.72 ± 8.79
P = 0.124
Table 3 Behaviour Rating Inventory of Executive Functioning-Second Edition parent symptom reports measured over the three-time points
Variable
BL T-score mean ± SD (n = 37)
BD T-score mean ± SD (n = 31)
BD-BL (P value)
FU T-score mean ± SD (n = 18)
FU-BD (P value)
Behavioural regulation index
72.43 ± 11.94
53.42 ± 8.78
P < 0.001
68.28 ± 13.23
P = 0.001
Metacognition index
74.76 ± 7.72
57.94 ± 8.48
P < 0.001
72.06 ± 9.51
P < 0.001
Table 4 Neuropsychological Test Performance Scores measured over the three-time points
Variable
BL T-score mean ± SD (n = 37)
BD T-score mean ± SD (n = 33)
BD-BL (P value)
FU T-score mean ± SD (n = 18)
FU-BD (P value)
CPT omission errors (T-Score)
61.11 ± 15.76
52.88 ± 8.09
P = 0.001
49.34 ± 5.90
P = 0.10
CPT commission errors (T-Score)
53.59 ± 6.74
49.70 ± 11.75
P = 0.097
49.69 ± 10.17
P = 0.04
Digit Span Backwards
95.54 ± 11.04
99.19 ± 11.48
P = 0.059
96.94 ± 15.54
P = 0.055
Spatial Span Backwards
105.68 ± 12.42
108.23 ± 13.0
P = 0.332
108.06 ± 12.96
P = 0.782
Citation: Hai T, Duffy HA, Lemay JA, Lemay JF. Impact of stimulant medication on behaviour and executive functions in children with attention-deficit/hyperactivity disorder. World J Clin Pediatr 2022; 11(1): 48-60